The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 26,985 | 322,513 | SH | SOLE | 322,513 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 30,289 | 400,016 | SH | SOLE | 400,016 | 0 | 0 | ||
ABIOMED, Inc. | Common | 003654100 | 5,820 | 32,716 | SH | SOLE | 32,716 | 0 | 0 | ||
AC Immune SA | Shares | H00263105 | 850 | 171,813 | SH | SOLE | 171,813 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 4,233 | 136,200 | SH | SOLE | 136,200 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 5,764 | 160,147 | SH | SOLE | 160,147 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 3,410 | 86,313 | SH | SOLE | 86,313 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 116 | 77,061 | SH | SOLE | 77,061 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 1,282 | 66,688 | SH | SOLE | 66,688 | 0 | 0 | ||
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 175 | 257,554 | SH | SOLE | 257,554 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 2,607 | 34,025 | SH | SOLE | 34,025 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 4,608 | 142,217 | SH | SOLE | 142,217 | 0 | 0 | ||
Alcon Inc. | Ordinary Shares | H01301128 | 3,227 | 55,369 | SH | SOLE | 55,369 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 44,454 | 453,887 | SH | SOLE | 453,887 | 0 | 0 | ||
Align Technology, Inc. | Common | 016255101 | 5,116 | 28,278 | SH | SOLE | 28,278 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 3,864 | 198,048 | SH | SOLE | 198,048 | 0 | 0 | ||
Allakos Inc. | Common | 01671P100 | 960 | 12,207 | SH | SOLE | 12,207 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 24,449 | 145,281 | SH | SOLE | 145,281 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 13,372 | 166,275 | SH | SOLE | 166,275 | 0 | 0 | ||
Amarin Corp. plc | Sponsored ADR | 023111206 | 4,375 | 288,557 | SH | SOLE | 288,557 | 0 | 0 | ||
AmerisourceBergen Corp. | Common | 03073E105 | 14,353 | 174,338 | SH | SOLE | 174,338 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 122,354 | 632,287 | SH | SOLE | 632,287 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 2,523 | 314,597 | SH | SOLE | 314,597 | 0 | 0 | ||
AnaptysBio, Inc. | Common | 032724106 | 2,362 | 67,496 | SH | SOLE | 67,496 | 0 | 0 | ||
Anthem, Inc. | Common | 036752103 | 29,084 | 121,132 | SH | SOLE | 121,132 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 2,380 | 98,784 | SH | SOLE | 98,784 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y506 | 192 | 36,068 | SH | SOLE | 36,068 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 2,739 | 582,698 | SH | SOLE | 582,698 | 0 | 0 | ||
Arena Pharmaceuticals, Inc. | Common | 040047607 | 1,282 | 28,002 | SH | SOLE | 28,002 | 0 | 0 | ||
Argenx SE | Sponsored ADR | 04016X101 | 3,880 | 34,048 | SH | SOLE | 34,048 | 0 | 0 | ||
ArQule, Inc. | Common | 04269E107 | 545 | 76,054 | SH | SOLE | 76,054 | 0 | 0 | ||
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 865 | 30,700 | SH | SOLE | 30,700 | 0 | 0 | ||
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 7,433 | 77,167 | SH | SOLE | 77,167 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 12,306 | 276,098 | SH | SOLE | 276,098 | 0 | 0 | ||
Atreca, Inc. | Class A Common | 04965G109 | 2,047 | 167,245 | SH | SOLE | 167,245 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 3,389 | 814,588 | SH | SOLE | 814,588 | 0 | 0 | ||
AVROBIO, Inc. | Common | 05455M100 | 285 | 20,176 | SH | SOLE | 20,176 | 0 | 0 | ||
Bausch Health Companies Inc. | Common | 071734107 | 3,689 | 168,812 | SH | SOLE | 168,812 | 0 | 0 | ||
Baxter International Inc. | Common | 071813109 | 14,429 | 164,958 | SH | SOLE | 164,958 | 0 | 0 | ||
Becton, Dickinson and Co. | Common | 075887109 | 14,782 | 58,438 | SH | SOLE | 58,438 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 11,547 | 94,289 | SH | SOLE | 94,289 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 63 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Bio-Techne Corp. | Common | 09073M104 | 5,975 | 30,537 | SH | SOLE | 30,537 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 60,053 | 257,939 | SH | SOLE | 257,939 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 1,215 | 29,125 | SH | SOLE | 29,125 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 16,564 | 245,763 | SH | SOLE | 245,763 | 0 | 0 | ||
Bluebird Bio, Inc. | Common | 09609G100 | 12,881 | 140,286 | SH | SOLE | 140,286 | 0 | 0 | ||
Blueprint Medicines Corp. | Common | 09627Y109 | 7,414 | 100,916 | SH | SOLE | 100,916 | 0 | 0 | ||
Boston Scientific Corp. | Common | 101137107 | 22,988 | 564,950 | SH | SOLE | 564,950 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 37,426 | 738,044 | SH | SOLE | 738,044 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 2,748 | 58,241 | SH | SOLE | 58,241 | 0 | 0 | ||
Celgene Corp. | Common | 151020104 | 146,339 | 1,473,710 | SH | SOLE | 1,473,710 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B202 | 15 | 7,053 | SH | SOLE | 7,053 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 1,146 | 110,147 | SH | SOLE | 110,147 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 3,318 | 25,067 | SH | SOLE | 25,067 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 317 | 158,784 | SH | SOLE | 158,784 | 0 | 0 | ||
Cigna Corp. | Common | 125523100 | 18,973 | 124,995 | SH | SOLE | 124,995 | 0 | 0 | ||
Clearside Biomedical, Inc. | Common | 185063104 | 104 | 165,330 | SH | SOLE | 165,330 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 3,954 | 195,146 | SH | SOLE | 195,146 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 734 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
CRISPR Therapeutics AG | Namen AKT | H17182108 | 4,154 | 101,336 | SH | SOLE | 101,336 | 0 | 0 | ||
CVS Health Corp. | Common | 126650100 | 34,076 | 540,286 | SH | SOLE | 540,286 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | Common | 23257D103 | 451 | 88,102 | SH | SOLE | 88,102 | 0 | 0 | ||
Danaher Corp. | Common | 235851102 | 22,008 | 152,376 | SH | SOLE | 152,376 | 0 | 0 | ||
DENTSPLY SIRONA Inc. | Common | 24906P109 | 7,300 | 136,936 | SH | SOLE | 136,936 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 1,053 | 214,845 | SH | SOLE | 214,845 | 0 | 0 | ||
Editas Medicine, Inc. | Common | 28106W103 | 3,364 | 147,939 | SH | SOLE | 147,939 | 0 | 0 | ||
Edwards Lifesciences Corp. | Common | 28176E108 | 14,347 | 65,240 | SH | SOLE | 65,240 | 0 | 0 | ||
Eli Lilly and Co. | Common | 532457108 | 17,553 | 156,958 | SH | SOLE | 156,958 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 1,706 | 531,570 | SH | SOLE | 531,570 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 4,122 | 399,604 | SH | SOLE | 399,604 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 7,829 | 213,562 | SH | SOLE | 213,562 | 0 | 0 | ||
Evolent Health, Inc. | Common | 30050B101 | 1,661 | 231,027 | SH | SOLE | 231,027 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 5,867 | 331,751 | SH | SOLE | 331,751 | 0 | 0 | ||
Fate Therapeutics, Inc. | Common | 31189P102 | 2,573 | 165,672 | SH | SOLE | 165,672 | 0 | 0 | ||
FibroGen, Inc. | Common | 31572Q808 | 8,622 | 233,142 | SH | SOLE | 233,142 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 914 | 300,781 | SH | SOLE | 300,781 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 1,395 | 9,141 | SH | SOLE | 9,141 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 116,238 | 1,833,982 | SH | SOLE | 1,833,982 | 0 | 0 | ||
GlaxoSmithKline PLC | Shares | 37733W105 | 9,891 | 231,758 | SH | SOLE | 231,758 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 4,510 | 92,957 | SH | SOLE | 92,957 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 837 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 7,419 | 64,499 | SH | SOLE | 64,499 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 11,848 | 98,393 | SH | SOLE | 98,393 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,621 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Inc. | Common | 421946104 | 2,278 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,351 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
HealthEquity, Inc. | Common | 42226A107 | 1,818 | 31,810 | SH | SOLE | 31,810 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 2,156 | 42,701 | SH | SOLE | 42,701 | 0 | 0 | ||
Horizon Therapeutics plc | Shares | G46188101 | 5,847 | 214,730 | SH | SOLE | 214,730 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 21,536 | 84,234 | SH | SOLE | 84,234 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 13,536 | 49,776 | SH | SOLE | 49,776 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 73,359 | 241,139 | SH | SOLE | 241,139 | 0 | 0 | ||
ImmunoGen, Inc. | Common | 45253H101 | 407 | 168,190 | SH | SOLE | 168,190 | 0 | 0 | ||
Immunomedics, Inc. | Common | 452907108 | 6,459 | 487,103 | SH | SOLE | 487,103 | 0 | 0 | ||
Incyte Corp. | Common | 45337C102 | 29,227 | 393,730 | SH | SOLE | 393,730 | 0 | 0 | ||
Inogen, Inc. | Common | 45780L104 | 2,948 | 61,526 | SH | SOLE | 61,526 | 0 | 0 | ||
Insmed Inc. | Common | 457669307 | 2,907 | 164,786 | SH | SOLE | 164,786 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 735 | 55,050 | SH | SOLE | 55,050 | 0 | 0 | ||
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 2,284 | 34,414 | SH | SOLE | 34,414 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 206 | 27,548 | SH | SOLE | 27,548 | 0 | 0 | ||
Intuitive Surgical, Inc. | Common | 46120E602 | 29,953 | 55,475 | SH | SOLE | 55,475 | 0 | 0 | ||
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 11,158 | 186,244 | SH | SOLE | 186,244 | 0 | 0 | ||
Iovance Biotherapeutics, Inc. | Common | 462260100 | 3,185 | 175,012 | SH | SOLE | 175,012 | 0 | 0 | ||
IQVIA Holdings Inc. | Common | 46266C105 | 4,460 | 29,857 | SH | SOLE | 29,857 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | Nasdaq Biotech | 464287556 | 1,882 | 18,914 | SH | SOLE | 18,914 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 9,602 | 74,936 | SH | SOLE | 74,936 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 105,862 | 818,227 | SH | SOLE | 818,227 | 0 | 0 | ||
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 1,970 | 42,700 | SH | SOLE | 42,700 | 0 | 0 | ||
Laboratory Corp. of America Holdings | Sponsored ADR | 50540R409 | 5,279 | 31,424 | SH | SOLE | 31,424 | 0 | 0 | ||
Ligand Pharmaceuticals Inc. | Common | 53220K504 | 4,385 | 44,055 | SH | SOLE | 44,055 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 7,448 | 145,421 | SH | SOLE | 145,421 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,150 | 13,340 | SH | SOLE | 13,340 | 0 | 0 | ||
Magenta Therapeutics, Inc. | Common | 55910K108 | 172 | 16,757 | SH | SOLE | 16,757 | 0 | 0 | ||
Mallinckrodt plc | Sponsored ADR | G5785G107 | 79 | 32,980 | SH | SOLE | 32,980 | 0 | 0 | ||
Masimo Corp. | Common | 574795100 | 3,933 | 26,436 | SH | SOLE | 26,436 | 0 | 0 | ||
McKesson Corp. | Common | 58155Q103 | 14,659 | 107,266 | SH | SOLE | 107,266 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 3,659 | 187,063 | SH | SOLE | 187,063 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 6,784 | 135,675 | SH | SOLE | 135,675 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 43,380 | 399,370 | SH | SOLE | 399,370 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 101,974 | 1,211,384 | SH | SOLE | 1,211,384 | 0 | 0 | ||
Merus N.V. | Common | N5749R100 | 382 | 21,421 | SH | SOLE | 21,421 | 0 | 0 | ||
Milestone Pharmaceuticals, Inc. | Common | 59935V107 | 812 | 46,940 | SH | SOLE | 46,940 | 0 | 0 | ||
Mirati Therapeutics, Inc. | Common | 60468T105 | 6,208 | 79,687 | SH | SOLE | 79,687 | 0 | 0 | ||
Molecular Templates, Inc. | Common | 608550109 | 950 | 144,110 | SH | SOLE | 144,110 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 20,543 | 1,038,554 | SH | SOLE | 1,038,554 | 0 | 0 | ||
MyoKardia, Inc. | Common | 62857M105 | 1,006 | 19,300 | SH | SOLE | 19,300 | 0 | 0 | ||
Myriad Genetics, Inc. | Common | 62855J104 | 538 | 18,805 | SH | SOLE | 18,805 | 0 | 0 | ||
Nektar Therapeutics | Common | 640268108 | 5,167 | 283,679 | SH | SOLE | 283,679 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 18,637 | 206,822 | SH | SOLE | 206,822 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 1,056 | 158,047 | SH | SOLE | 158,047 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 21,677 | 249,447 | SH | SOLE | 249,447 | 0 | 0 | ||
Novavax, Inc. | Common | 670002401 | 143 | 28,550 | SH | SOLE | 28,550 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 12,460 | 241,000 | SH | SOLE | 241,000 | 0 | 0 | ||
Novocure Ltd. | Ordinary Shares | G6674U108 | 7,548 | 100,932 | SH | SOLE | 100,932 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 11,399 | 272,766 | SH | SOLE | 272,766 | 0 | 0 | ||
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 1,208 | 372,733 | SH | SOLE | 372,733 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | Common | 69404D108 | 2,557 | 495,495 | SH | SOLE | 495,495 | 0 | 0 | ||
PerkinElmer, Inc. | Common | 714046109 | 1,619 | 19,011 | SH | SOLE | 19,011 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 605 | 10,818 | SH | SOLE | 10,818 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 75,967 | 2,114,306 | SH | SOLE | 2,114,306 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 5,394 | 303,908 | SH | SOLE | 303,908 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 4,942 | 1,449,269 | SH | SOLE | 1,449,269 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 3,096 | 115,448 | SH | SOLE | 115,448 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 15,182 | 153,003 | SH | SOLE | 153,003 | 0 | 0 | ||
PTC Therapeutics, Inc. | Common | 69366J200 | 5,020 | 148,435 | SH | SOLE | 148,435 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 768 | 71,340 | SH | SOLE | 71,340 | 0 | 0 | ||
Quest Diagnostics Inc. | Common | 74834L100 | 2,784 | 26,012 | SH | SOLE | 26,012 | 0 | 0 | ||
Quorum Health Corp. | Common | 74909E106 | 29 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Quotient Ltd. | Common | G73268107 | 2,020 | 260,030 | SH | SOLE | 260,030 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 1,320 | 55,829 | SH | SOLE | 55,829 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 44,289 | 159,658 | SH | SOLE | 159,658 | 0 | 0 | ||
REGENXBIO Inc. | Common | 75901B107 | 3,889 | 109,248 | SH | SOLE | 109,248 | 0 | 0 | ||
ResMed Inc. | Common | 761152107 | 5,014 | 37,110 | SH | SOLE | 37,110 | 0 | 0 | ||
Rocket Pharmaceuticals, Inc. | Common | 77313F106 | 2,418 | 207,555 | SH | SOLE | 207,555 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 10,705 | 466,247 | SH | SOLE | 466,247 | 0 | 0 | ||
Sage Therapeutics Inc | Common | 78667J108 | 12,174 | 86,780 | SH | SOLE | 86,780 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 3,982 | 85,941 | SH | SOLE | 85,941 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 10,566 | 140,279 | SH | SOLE | 140,279 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 24,760 | 289,925 | SH | SOLE | 289,925 | 0 | 0 | ||
Senior Housing Properties Trust | Common | 81721M109 | 3,311 | 357,720 | SH | SOLE | 357,720 | 0 | 0 | ||
Smith & Nephew plc | Shares | 83175M205 | 5,855 | 121,645 | SH | SOLE | 121,645 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 6,788 | 89,022 | SH | SOLE | 89,022 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 951 | 114,670 | SH | SOLE | 114,670 | 0 | 0 | ||
STERIS plc | Shares | G8473T100 | 3,536 | 24,473 | SH | SOLE | 24,473 | 0 | 0 | ||
Stryker Corp. | Common | 863667101 | 25,636 | 118,520 | SH | SOLE | 118,520 | 0 | 0 | ||
Sutro Biopharma, Inc. | Common | 869367102 | 5,829 | 641,268 | SH | SOLE | 641,268 | 0 | 0 | ||
Syneos Health, Inc. | Class A | 87166B102 | 2,447 | 45,982 | SH | SOLE | 45,982 | 0 | 0 | ||
Takeda Pharmaceutic | Sponsored ADS | 874060205 | 3,615 | 210,146 | SH | SOLE | 210,146 | 0 | 0 | ||
Teleflex Inc. | Common | 879369106 | 2,167 | 6,379 | SH | SOLE | 6,379 | 0 | 0 | ||
Tenet Healthcare Corp. | Common | 88033G407 | 3,122 | 141,136 | SH | SOLE | 141,136 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N204 | 229 | 42,966 | SH | SOLE | 42,966 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 5,407 | 785,851 | SH | SOLE | 785,851 | 0 | 0 | ||
Theravance Biopharma, Inc. | Common | G8807B106 | 898 | 46,101 | SH | SOLE | 46,101 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 26,013 | 89,310 | SH | SOLE | 89,310 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 137 | 446,099 | SH | SOLE | 446,099 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 4,170 | 97,480 | SH | SOLE | 97,480 | 0 | 0 | ||
uniQure B.V. | Shares | N90064101 | 1,726 | 43,849 | SH | SOLE | 43,849 | 0 | 0 | ||
United Therapeutics Corp. | Class B | 91307C102 | 4,314 | 54,094 | SH | SOLE | 54,094 | 0 | 0 | ||
Unitedhealth Group Inc. | Common | 91324P102 | 73,298 | 337,283 | SH | SOLE | 337,283 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 10,306 | 141,119 | SH | SOLE | 141,119 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 1,257 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 82,547 | 487,234 | SH | SOLE | 487,234 | 0 | 0 | ||
WaVe Life Sciences Ltd. | Shares | Y95308105 | 2,516 | 122,551 | SH | SOLE | 122,551 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 13,808 | 152,322 | SH | SOLE | 152,322 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 2,558 | 124,006 | SH | SOLE | 124,006 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 5,000 | 148,231 | SH | SOLE | 148,231 | 0 | 0 | ||
Zai Lab Ltd. | ADR | 98887Q104 | 1,214 | 37,523 | SH | SOLE | 37,523 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 10,648 | 77,571 | SH | SOLE | 77,571 | 0 | 0 | ||
Zoetis Inc. | Class A | 98978V103 | 31,026 | 249,024 | SH | SOLE | 249,024 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L204 | 2,485 | 62,074 | SH | SOLE | 62,074 | 0 | 0 | ||
Zymeworks Inc. | Common | 98985W102 | 377 | 15,192 | SH | SOLE | 15,192 | 0 | 0 |